Digital health is a fast growing segment of the health industry which ranges from being medical/clinical related to other focuses like general well-being. Innovation in digital health is driven by the need for advanced analytical tools and applications. At the same time with rapidly growing innovations, the landscape of technology regulation is also evolving. Join HBA San Francisco and the HBA Women in Science (WIS) affinity group for an interactive discussion with thought leaders from the diagnostics industry about the impact of digital health innovations on patient care and the complexities of digital health regulation strategies.
If arriving by car, parking is available at the Roche Pleasanton, CA site. The site is also easily accessible from SF/Walnut Creek areas by taking BART to the Dublin/Pleasanton stop and walking from there.
05:30PM-06:30PM Registration and Networking
06:30PM-06:45PM Welcome and HBA Introduction
06:45PM-07:30PM Panel Session / Q&A
07:30PM-08:00PM Closing Remarks and Networking
Event is open to: HBA members and sponsor employees
Online registration deadline: 10/29/2019
Onsite (walk-in) registration: Is NOT allowed
This event is refundable, requests must be submitted in writing to email@example.com
by October 28, 2019
1. Get a better understanding of the complex landscape of digital health molecular diagnostics, and how it has the potential to positively impact patient care.
2. Continue to learn, grow and transform by seeking experiences and opportunities to improve knowledge, skills and behavior; remains a life-long learner.
3. Fosters innovation by translating insights into ideas and shares with colleagues and stakeholders